IL72430A - 2-(formylamino)-n-(1h-tetrazol-5-yl)-benzamide - Google Patents

2-(formylamino)-n-(1h-tetrazol-5-yl)-benzamide

Info

Publication number
IL72430A
IL72430A IL72430A IL7243084A IL72430A IL 72430 A IL72430 A IL 72430A IL 72430 A IL72430 A IL 72430A IL 7243084 A IL7243084 A IL 7243084A IL 72430 A IL72430 A IL 72430A
Authority
IL
Israel
Prior art keywords
tetrazol
benzamide
formylamino
amino
compounds
Prior art date
Application number
IL72430A
Other languages
English (en)
Other versions
IL72430A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL72430A0 publication Critical patent/IL72430A0/xx
Publication of IL72430A publication Critical patent/IL72430A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Photolithography (AREA)
  • Paints Or Removers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL72430A 1983-07-22 1984-07-18 2-(formylamino)-n-(1h-tetrazol-5-yl)-benzamide IL72430A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/517,086 US4567193A (en) 1983-07-22 1983-07-22 2-(Formylamino)-N-(1H-tetrazol-5-yl)benzamide and use as anti-allergics

Publications (2)

Publication Number Publication Date
IL72430A0 IL72430A0 (en) 1984-11-30
IL72430A true IL72430A (en) 1987-11-30

Family

ID=24058297

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72430A IL72430A (en) 1983-07-22 1984-07-18 2-(formylamino)-n-(1h-tetrazol-5-yl)-benzamide

Country Status (18)

Country Link
US (1) US4567193A (ko)
EP (1) EP0132788B1 (ko)
JP (1) JPS6042372A (ko)
KR (1) KR890000663B1 (ko)
AT (1) ATE31925T1 (ko)
AU (1) AU564328B2 (ko)
CA (1) CA1220210A (ko)
DE (1) DE3468683D1 (ko)
DK (1) DK159775C (ko)
ES (1) ES8601164A1 (ko)
GR (1) GR82100B (ko)
HU (1) HU191432B (ko)
IE (1) IE57584B1 (ko)
IL (1) IL72430A (ko)
NO (1) NO168642C (ko)
NZ (1) NZ208934A (ko)
PT (1) PT78931B (ko)
ZA (1) ZA845517B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879295A (en) * 1986-09-27 1989-11-07 Sawai Pharmaceutical Co., Ltd. N-tetrazolyl thiazolecarboxyamide derivatives and their use
EP0321115B1 (en) * 1987-12-14 1991-08-14 Sawai Pharmaceutical Co., Ltd. Carboxamide derivatives having tetrazole and thiazole rings and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561350A (en) * 1976-11-05 1980-02-20 May & Baker Ltd Benzamide derivatives
CH630619A5 (en) * 1978-01-01 1982-06-30 May & Baker Ltd New derivatives of N-(5-tetrazolyl)benzamide

Also Published As

Publication number Publication date
HUT34460A (en) 1985-03-28
NZ208934A (en) 1987-01-23
NO168642C (no) 1992-03-18
DE3468683D1 (de) 1988-02-18
PT78931B (en) 1986-09-08
ATE31925T1 (de) 1988-01-15
AU564328B2 (en) 1987-08-06
EP0132788A1 (en) 1985-02-13
JPS6042372A (ja) 1985-03-06
JPH0369347B2 (ko) 1991-10-31
EP0132788B1 (en) 1988-01-13
DK159775B (da) 1990-12-03
DK358484A (da) 1985-01-23
NO842968L (no) 1985-01-23
IL72430A0 (en) 1984-11-30
AU3052784A (en) 1985-01-24
US4567193A (en) 1986-01-28
HU191432B (en) 1987-02-27
ES534533A0 (es) 1985-10-16
ZA845517B (en) 1985-03-27
IE57584B1 (en) 1993-01-13
DK358484D0 (da) 1984-07-20
GR82100B (ko) 1984-12-13
KR850001182A (ko) 1985-03-16
CA1220210A (en) 1987-04-07
IE841893L (en) 1985-01-22
ES8601164A1 (es) 1985-10-16
KR890000663B1 (ko) 1989-03-22
PT78931A (en) 1984-08-01
NO168642B (no) 1991-12-09
DK159775C (da) 1991-05-06

Similar Documents

Publication Publication Date Title
SE8301008D0 (sv) Pyrrolacetic amide having antiinflammatory activity
IL72430A (en) 2-(formylamino)-n-(1h-tetrazol-5-yl)-benzamide
AU570852B2 (en) Tetrazole benzamides
GR82102B (ko)
GB2135997B (en) N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
SE8601963D0 (sv) O-sulfated beta-lactam hydroxamic acids
DK0422846T3 (da) Aroylurinstoffer
PT82535A (en) Pharmacologically active propionylanilides

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.